Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria

被引：39

作者：

Brown-Elliott, BA ^{[1
]}

Wallace, RJ ^{[1
]}

Crist, CJ ^{[1
]}

Mann, L ^{[1
]}

Wilson, RW ^{[1
]}

机构：

[1] Univ Texas Hlth Ctr, Dept Microbiol, Tyler, TX 75708 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2002年 / 46卷 / 10期

关键词：

D O I：

10.1128/AAC.46.10.3283-3285.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

By using current NCCLS broth microdilution methods, we found that gatifloxacin inhibited 90% of the isolates of the Mycobacterium fortuitum group at less than or equal to0.12 mug/ml and 90% of the Mycobacterium chelonae isolates at less than or equal to4 mug/ml. Gatifloxacin was generally fourfold more active than ciprofloxacin. We recommend that both gatifloxacin and ciprofloxacin be tested routinely against rapidly growing mycobacteria.

引用

页码：3283 / 3285

页数：3

共 16 条

[1] Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
Bauernfeind, A
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) : 639 - 651
[2] ACTIVITIES OF 4 MACROLIDES, INCLUDING CLARITHROMYCIN, AGAINST MYCOBACTERIUM-FORTUITUM, MYCOBACTERIUM-CHELONAE, AND M-CHELONAE-LIKE ORGANISMS
BROWN, BA
WALLACE, RJ
ONYI, GO
DEROSAS, V
WALLACE, RJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) : 180 - 184
[3] Mycobacterium wolinskyi sp nov and Mycobacterium goodii sp nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections:: a cooperative study from the International Working Group on Mycobacterial Taxonomy
Brown, BA
Springer, B
Steingrube, VA
Wilson, RW
Pfyffer, GE
Garcia, MJ
Menendez, MC
Rodriguez-Salgado, B
Jost, KC
Chiu, SH
Onyi, GO
Böttger, EC
Wallace, RJ
[J]. INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1999, 49 : 1493 - 1511
[4] Successful treatment of disseminated Mycobacterium chelonae infection with linezolid
Brown-Elliot, BA
Wallace, RJ
Blinkhorn, R
Crist, CJ
Mann, LB
[J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) : 1433 - 1434
[5] Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from the SENTRY Antimicrobial Surveillance Program (1997-99)
Jones, RN
Pfaller, MA
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 39 (04) : 237 - 243
[6] *NCCLS, 2002, PERF STAND ANT SUS S
[7] PCR AMPLIFICATION AND RESTRICTION-ENDONUCLEASE ANALYSIS OF A 65-KILODALTON HEAT-SHOCK PROTEIN GENE SEQUENCE FOR TAXONOMIC SEPARATION OF RAPIDLY GROWING MYCOBACTERIA
STEINGRUBE, VA
GIBSON, JL
BROWN, BA
ZHANG, YS
WILSON, RW
RAJAGOPALAN, M
WALLACE, RJ
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) : 149 - 153
[8] RAPID DEVELOPMENT OF RESISTANCE TO CLARITHROMYCIN FOLLOWING MONOTHERAPY FOR DISSEMINATED MYCOBACTERIUM-CHELONAE INFECTION IN A HEART-TRANSPLANT PATIENT
TEBAS, P
SULTAN, F
WALLACE, RJ
FRASER, V
[J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (02) : 443 - 444
[9] RAPID IDENTIFICATION OF MYCOBACTERIA TO THE SPECIES LEVEL BY POLYMERASE CHAIN-REACTION AND RESTRICTION ENZYME ANALYSIS
TELENTI, A
MARCHESI, F
BALZ, M
BALLY, F
BOTTGER, EC
BODMER, T
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (02) : 175 - 178
[10] Wallace R. J. Jr, 1985, Antimicrobic Newsletter, V2, P85, DOI 10.1016/0738-1751(85)90004-8

← 1 2 →